首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2677805篇
  免费   200188篇
  国内免费   13951篇
耳鼻咽喉   35058篇
儿科学   86808篇
妇产科学   72517篇
基础医学   371732篇
口腔科学   71487篇
临床医学   248022篇
内科学   525843篇
皮肤病学   63417篇
神经病学   216425篇
特种医学   103267篇
外国民族医学   772篇
外科学   392668篇
综合类   72787篇
现状与发展   39篇
一般理论   969篇
预防医学   205610篇
眼科学   59304篇
药学   199878篇
  193篇
中国医学   14049篇
肿瘤学   151099篇
  2021年   25289篇
  2019年   23719篇
  2018年   32402篇
  2017年   26293篇
  2016年   29150篇
  2015年   34360篇
  2014年   46487篇
  2013年   66927篇
  2012年   89323篇
  2011年   94158篇
  2010年   58157篇
  2009年   54990篇
  2008年   85331篇
  2007年   89683篇
  2006年   90929篇
  2005年   85886篇
  2004年   81517篇
  2003年   78614篇
  2002年   75256篇
  2001年   129958篇
  2000年   132500篇
  1999年   111307篇
  1998年   31678篇
  1997年   28319篇
  1996年   28510篇
  1995年   27669篇
  1994年   25282篇
  1993年   23516篇
  1992年   85243篇
  1991年   81634篇
  1990年   78856篇
  1989年   76104篇
  1988年   69520篇
  1987年   68025篇
  1986年   63560篇
  1985年   60522篇
  1984年   44947篇
  1983年   37945篇
  1982年   22461篇
  1981年   19990篇
  1979年   38967篇
  1978年   27441篇
  1977年   23254篇
  1976年   21497篇
  1975年   22813篇
  1974年   26788篇
  1973年   25370篇
  1972年   23751篇
  1971年   21955篇
  1970年   20188篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
Introduction: The Hedgehog (HH) pathway constitutes a collection of signaling molecules which critically influence embryogenesis. In adults, however, the HH pathway remains integral to the proliferation, maintenance, and apoptosis of adult stem cells including hematopoietic stem cells.

Areas covered: We discuss the current understanding of the HH pathway as it relates to normal hematopoiesis, the pathology of acute myeloid leukemia (AML), the rationale for and data from combination therapies including HH pathway inhibitors, and ultimately the prospects that might offer promise in targeting this pathway in AML.

Expert opinion: Efforts to target the HH pathway have been focused on impeding this disposition and restoring chemosensitivity to conventional myeloid neoplasm therapies. The year 2018 saw the first approval of a HH pathway inhibitor (glasdegib) for AML, though for an older population and in combination with an uncommonly-used therapy. Several other clinical trials with agents targeting modulators of HH signaling in AML and MDS are underway. Further study and understanding of the interplay between the numerous aspects of HH signaling and how it relates to the augmented survival of AML will provide a more reliable substrate for therapeutic strategies in patients with this poor-risk disease.  相似文献   

44.
夏靖  倪诚 《天津中医药》2019,36(12):1149-1152
中医对于脂溢性脱发,传统多按"血热风燥""血虚风燥""湿热""肝肾不足"等分型论治,虽能取得一定的临床疗效,暂时缓解病情,但难以根治,给患者带来困扰。倪诚教授根据国医大师王琦教授所提出的"肤-体相关论""体质可调论",认为湿热体质是脂溢性脱发发病的主要土壤,指出瘀浊蛀发是脂溢性脱发的病机要点,治疗上以清利湿热调体治本、凉血活血为主、佐以滋养肝肾,方用茵陈蒿汤合升降散加减配合外洗经验方,从标本兼顾、分期论治、内服外洗等方面治疗脂溢性脱发,在临床上取得良好的疗效。  相似文献   
45.
46.
47.
We review the spectrum of cutaneous disorders associated with inflammatory and neoplastic plasmacytic pathology. Because plasma cells are derived from B‐lymphocytes our overview includes discussion of certain lymphoplasmacytic proliferations. It is structured along histopathological lines, addressing conditions characterized by (a) cutaneous plasma cell infiltrates, (b) deposits of plasma cell products or their derivatives in the skin and (c) miscellaneous, poorly understood cutaneous complications of plasmacytic disorders. Lesions arising primarily in the skin and those due to cutaneous involvement by multisystem disorders are addressed. The range includes a spectrum of tumefactive and circulatory manifestations. We highlight key clinical and pathological features of the different conditions and outline recent advances in our understanding of these entities. By emphasizing the dermatopathological characteristics of this spectrum of disorders we hope to hone the diagnostic accuracy of practitioners in the field.  相似文献   
48.
BackgroundThe aim of this study was to estimate the prevalence of dental prosthetic treatment and to investigate the demographic, social, economic and medical factors associated with the use of fixed and removable dentures in a representative sample of adults living in France.MethodsThe data were obtained from the 2002–2003 Decennial Health Survey, a cross-sectional study of a representative sample of the population living in France, which included 29,679 adults. Information was collected by interview. The variables collected were fixed denture, removable denture, age, gender, number of children, area of residence, nationality, educational attainment, family social status, employment status, annual household income per capita, supplementary insurance, chronic disease, eyesight problems/glasses, hearing problems/hearing aids. Multinomial logistic regression models were used to study the relationship between prosthetic treatment and demographic, socioeconomic and medical characteristics unadjusted, adjusted for age and adjusted for all the characteristics.ResultsThe prevalence of prosthetic treatment was 34.6% (95% confidence interval (CI): [34.1; 35.2]) for fixed prosthetic dentures and 13.8% (95% CI: [13.4; 14.2]) for removable prosthetic dentures. We showed a gradient between educational attainment and removable dentures; the odds ratio adjusted for all the variables (aOR) associated with no or primary education compared to post-secondary education was 2.56; 95% CI: [2.09; 3.13]. When annual household income per capita was low, subjects were less likely to report fixed dentures (aOR = 0.68; 95% CI: [0.62; 0.75]) than those with high annual household income per capita. Individuals without insurance less often reported fixed dentures than those with private insurance. Those reporting chronic disease were less likely to report fixed dentures (aOR = 0.87; 95% CI: [0.79; 0.95]) but more likely to report removable dentures (aOR = 1.29; 95% CI: [1.17; 1.43]) than those without chronic disease.ConclusionThis study reveals social, economic and medical inequalities in fixed and removable prosthetic treatment among adults in France.  相似文献   
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号